Digital diabetes management company Glooko has acquired Paris-based DIABNEXT, a fellow diabetes care platform. DIABNEXT's app tracks patient diabetes metrics, allowing providers to monitor that data ...

In its second acquisition of the year so far, Glooko is forging ahead in its mission not only to bulk up its digital diabetes management offerings but also to expand their reach around the world.

Glooko and Hedia launched their interoperable solution, combining connected care, remote patient monitoring, and digital therapeutics for diabetes.

Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States January 04, 2024 02:00 PM Eastern Standard Time ...

It also purchased Paris-based DIABNEXT, a company that offers a digital health platform to help people with diabetes manage their condition and connect with their healthcare provider. In 2021, Glooko ...

Glooko provides a remote patient monitoring and chronic care management solution for diabetes and obesity. It integrates 95 percent of all diabetes devices on the marketplace, supporting its partners’ ...

After beginning the U.S. launch of its AspyreRx digital therapeutic for Type 2 diabetes last fall, Better Therapeutics is ramping up that rollout.

PALO ALTO, Calif. and PARIS, March 16, 2022 /PRNewswire/ – Glooko Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions ...

Digital diabetes management tools fail to provide meaningful clinical benefits and increase health spending, a new report from the Peterson Health Technology Institute (PHTI) shows.

This expands upon the existing reimbursement for Glooko XT for remote monitoring of people with insulin-treated diabetes, making it one of only two solutions in France with this GDM indication and ...

PALO ALTO, Calif. and PARIS, March 16, 2022 /PRNewswire/ – Glooko Inc., a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions ...